A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on hormone treatments for menopause, arguing that the strong warning has likely ...

A new study suggests that hormone therapy, often used to ease symptoms of menopause like hot flashes and night sweats, may ...

Hormone replacement therapy (HRT) is a medical treatment that aims to alleviate the symptoms of menopause by replenishing hormones like estrogen and progesterone, which naturally decrease as women ...